Javier C. C.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Safety and Efficacy of Elacestrant in Combination Therapies for Patients with Metastatic Breast Cancer: A Phase 1b/2 Open-Label Umbrella Study
- Phase 1 Evaluation of BL-B01D1 Safety, Tolerability, and Efficacy in Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors
- Phase I Study of OKI-219 Monotherapy and in Combination with Endocrine or HER2-Targeted Therapy in Advanced Solid Tumors and Breast Cancer
Data & Insights
Has run more than one trial at 359 of 624 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in advanced therapeutic approaches for triple-negative breast cancer (TNBC) and hormone receptor-low/HER2-negative breast cancer. Their research encompasses both metastatic and locally recurrent cases, with particular attention to treatment-resistant forms of the disease.
- Metastatic breast cancer management
- Neoadjuvant and adjuvant therapy approaches
- PD-L1 positive breast cancer treatment
Their work includes investigating innovative therapeutic combinations for breast cancer patients, particularly focusing on immunotherapy-based treatments.
Immunotherapy Applications
The investigator focuses on developing combination immunotherapy approaches, particularly exploring the integration of targeted therapies with immune checkpoint inhibitors. Their expertise extends to evaluating novel therapeutic combinations for enhanced treatment outcomes.
- Immune checkpoint inhibitor combinations
- Targeted therapy integration
- Treatment resistance mechanisms
Their research emphasizes personalizing immunotherapy approaches based on specific biomarker profiles.
Solid Tumor Therapeutics
The investigator conducts research in advanced solid tumor treatment, with a focus on evaluating novel therapeutic agents. Their work encompasses early-phase clinical development and the assessment of innovative treatment approaches.
- Novel therapeutic agent evaluation
- Dose optimization strategies
- Advanced solid tumor management
Their expertise includes investigating emerging therapeutic compounds for various solid tumor types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.